$71.37
+1.68 (+2.41%)
At Close: Jun 04, 2026
Why TransMedics Group Stock Is Soaring Today
11:30am, Thursday, 01'st Aug 2024
TransMedics Group reported significant top- and bottom-line improvement in Q2. The company raised its full-year revenue guidance.
TransMedics Group Raises Full-Year Guidance
08:42am, Thursday, 01'st Aug 2024
Revenue of $114.3 million, a 118% increase year over year. Full-year revenue guidance increased to $425 million to $445 million.
TransMedics Group, Inc. (TMDX) Q2 2024 Earnings Call Transcript
11:28pm, Wednesday, 31'st Jul 2024
TransMedics Group, Inc. (TMDX) Q2 2024 Earnings Call Transcript
TransMedics (TMDX) Q2 Earnings and Revenues Top Estimates
06:46pm, Wednesday, 31'st Jul 2024
TransMedics (TMDX) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to loss of $0.03 per share a year ago.
TransMedics Reports Second Quarter 2024 Financial Results
04:05pm, Wednesday, 31'st Jul 2024
ANDOVER, Mass. , July 31, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-
TransMedics to Present at the Canaccord Genuity 44th Annual Growth Conference
04:05pm, Monday, 29'th Jul 2024
ANDOVER, Mass. , July 29, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-
Wall Street's Insights Into Key Metrics Ahead of TransMedics (TMDX) Q2 Earnings
10:21am, Monday, 29'th Jul 2024
Get a deeper insight into the potential performance of TransMedics (TMDX) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for s
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04:05pm, Thursday, 18'th Jul 2024
ANDOVER, Mass. , July 18, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-
TransMedics to Report Second Quarter 2024 Financial Results on July 31, 2024
04:05pm, Wednesday, 17'th Jul 2024
ANDOVER, Mass. , July 17, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end
TransMedics (TMDX) Moves to Buy: Rationale Behind the Upgrade
01:05pm, Tuesday, 16'th Jul 2024
TransMedics (TMDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
5 Growth Stocks Poised to Grow Faster than NVIDIA Next Year
08:00am, Saturday, 06'th Jul 2024
In 2024, the fastest-growing stocks have been in the momentum category, led by NVIDIA (NASDAQ: NVDA).
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
05:50am, Friday, 28'th Jun 2024
Vertex Pharmaceuticals could have multiple new blockbusters on the way. Viking Therapeutics is targeting two massive markets -- obesity and NASH.
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04:05pm, Friday, 21'st Jun 2024
ANDOVER, Mass. , June 21, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-
The 3 Best Medical Device Stocks to Buy in June 2024
03:58pm, Thursday, 20'th Jun 2024
Medical devices are spearheading the digitalization of healthcare, reports analytics and software development company Luxoft. Specifically, medical devices are “providing accurate diagnoses, effecti
Top 4 Health Care Stocks That May Keep You Up At Night This Month
08:44am, Tuesday, 11'th Jun 2024
As of June 11, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Sign In
Buy TMDX